WeVote
Log In

Bill

Bill

S 1586

An Act relative to smoking cessation agents

194th Legislature (2025-2026) Introduced by Mike Moore

S 1586 modifies Massachusetts smoking cessation agent regulations, advancing through committee toward potential changes in treatment access or coverage requirements for nicotine addiction medications.

Accompanied a study order, see S2931
0
WeVote Research Nonpartisan
Bill Summary · S 1586

Legislative bill overview

S 1586 proposes changes to Massachusetts law regarding smoking cessation agents—medications and products designed to help people quit smoking, such as nicotine replacement therapies (patches, gum, lozenges) and prescription drugs (varenicline, bupropion). The bill has advanced through committee review and is currently under consideration by the Health Care Financing committee, though the specific provisions are not detailed in the available legislative record.

Why is this important

Smoking cessation policy affects public health outcomes, healthcare costs, and tobacco control efforts in Massachusetts. Changes to how cessation agents are regulated, covered, or distributed could impact access to quit-smoking treatments for thousands of residents and influence state healthcare spending on addiction treatment.

Potential points of contention

  • Insurance coverage requirements: Disagreement over whether health insurers should be mandated to cover cessation agents without cost-sharing, and at what level of coverage
  • Scope and approval of agents: Debate over which smoking cessation products qualify for regulation or subsidy under the bill's framework
  • Funding mechanisms: Questions about how the state will pay for expanded cessation agent access or requirements, potentially affecting healthcare budgets

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.